|
|
|||
|
||||
OverviewFor the diagnosis of biochemical recurrence of prostate cancer, fluorine-18 labeled Choline PET/CT has been used in Spain, which has a variable detection rate and is subject to PSA values prior to the study. It has been known for some years that Prostate Specific Membrane Antigen (PSMA) is overexpressed in most prostate cancers and represents an ideal molecular target for diagnostic and therapeutic purposes. In the last decade a new radiopharmaceutical, 18F-DCFPyL, has been developed that binds to the extracellular domain of PSMA and may allow a more sensitive and accurate method for the detection of early tumor recurrence. Currently in Spain, 18F-DCFPyL is being used as a drug in special situations and is not yet authorized for marketing. It would be important to establish the diagnostic value of this radiopharmaceutical that will allow greater diagnostic accuracy. Full Product DetailsAuthor: �ngela Alonso Garc�aPublisher: Our Knowledge Publishing Imprint: Our Knowledge Publishing Dimensions: Width: 15.20cm , Height: 0.30cm , Length: 22.90cm Weight: 0.095kg ISBN: 9786207426850ISBN 10: 6207426851 Pages: 56 Publication Date: 24 April 2024 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |